Zdrowie i gospodarka · 20/10/2009

FDA Requests Public Comment on Proposed Waiver Applications for In Vitro Diagnostic Devices Under Clinical Laboratory Improvement Amendments of 1988

The Food and Drug Administration (FDA) is seeking public input on proposed waiver applications for manufacturers of in vitro diagnostic devices under the Clinical Laboratory Improvement Amendments of 1988, as part of its efforts to improve clinical laboratory standards.